TY - JOUR
T1 - HIRA-TAN
T2 - A real-time PCR-based system for the rapid identification of causative agents in pneumonia
AU - Hirama, Takashi
AU - Minezaki, Shohei
AU - Yamaguchi, Takefumi
AU - Kishi, Etsuko
AU - Kodama, Keiji
AU - Egashira, Hiroshi
AU - Kobayashi, Kunihiko
AU - Nagata, Makoto
AU - Ishii, Toshiaki
AU - Nemoto, Manabu
AU - Tanaka, Masahiko
AU - Fukunaga, Koichi
AU - Kanazawa, Minoru
AU - Hagiwara, Koichi
PY - 2014/2
Y1 - 2014/2
N2 - Identification of the causative pathogen(s) of pneumonia would allow the selection of effective antibiotics and thus reduce the mortality rate and the emergence of drug-resistant pathogens. To identify such pathogens and to obtain these benefits, it is necessary that a clinical test is rapid, accurate, easily performed, and cost-effective. Here, we devised a PCR-based test, named HIRA-TAN, which is able to discriminate therapeutic targets from commensal organisms (e.g. Streptococcus pneumoniae or Haemophilus influenzae) and to detect foreign organisms (e.g. Mycoplasma pneumoniae or Legionella pneumophila) in the sputum. The utility of this system was validated in a prospective study, using sputum samples from patients with pneumonia. 568 patients were enrolled and the HIRA-TAN assay identified the causative pathogens with an accuracy of 96.7% for H. influenzae; 93.2% for Pseudomonas aeruginosa; 80.6% for Klebsiella pneumoniae; 90.9% for Moraxella catarrhalis; 87.5% for Escherichia coli; 78.1% for MRSA and 91.6% for S. pneumoniae. Overall the HIRA-TAN procedure was able to identify the causative pathogens of pneumonia in 60% of the cases. Additionally, this procedure was able to determine when the pneumonia-causing organism was a commensal organism or a foreign organism in a single assay. The HIRA-TAN approach yielded reproducible results and provided valuable information to plan the course of treatment of pneumonia. Through the rapid identification of the causative pathogens, the HIRA-TAN will promote targeted treatments for pneumonias. Clinical Trials Registration: UMIN000001694.
AB - Identification of the causative pathogen(s) of pneumonia would allow the selection of effective antibiotics and thus reduce the mortality rate and the emergence of drug-resistant pathogens. To identify such pathogens and to obtain these benefits, it is necessary that a clinical test is rapid, accurate, easily performed, and cost-effective. Here, we devised a PCR-based test, named HIRA-TAN, which is able to discriminate therapeutic targets from commensal organisms (e.g. Streptococcus pneumoniae or Haemophilus influenzae) and to detect foreign organisms (e.g. Mycoplasma pneumoniae or Legionella pneumophila) in the sputum. The utility of this system was validated in a prospective study, using sputum samples from patients with pneumonia. 568 patients were enrolled and the HIRA-TAN assay identified the causative pathogens with an accuracy of 96.7% for H. influenzae; 93.2% for Pseudomonas aeruginosa; 80.6% for Klebsiella pneumoniae; 90.9% for Moraxella catarrhalis; 87.5% for Escherichia coli; 78.1% for MRSA and 91.6% for S. pneumoniae. Overall the HIRA-TAN procedure was able to identify the causative pathogens of pneumonia in 60% of the cases. Additionally, this procedure was able to determine when the pneumonia-causing organism was a commensal organism or a foreign organism in a single assay. The HIRA-TAN approach yielded reproducible results and provided valuable information to plan the course of treatment of pneumonia. Through the rapid identification of the causative pathogens, the HIRA-TAN will promote targeted treatments for pneumonias. Clinical Trials Registration: UMIN000001694.
KW - Commensal organism
KW - Foreign organism
KW - HIRA-TAN
KW - Pneumonia
KW - Real-time PCR
UR - http://www.scopus.com/inward/record.url?scp=84893718369&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893718369&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2013.11.018
DO - 10.1016/j.rmed.2013.11.018
M3 - Article
C2 - 24411834
AN - SCOPUS:84893718369
SN - 0954-6111
VL - 108
SP - 395
EP - 404
JO - Respiratory Medicine
JF - Respiratory Medicine
IS - 2
ER -